5-HTTLPR polymorphism, mood disorders and MDMA use in a 3-year follow-up study.

5-HTTLPR polymorphism, mood disorders and MDMA use in a 3-year follow-up study.

Item
http://www.wikidata.org/entity/Q43251705
Clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"): the influence of gender and genetics (CYP2D6, COMT, 5-HTT)5-HTTLPR Genotype Moderates the Effects of Past Ecstasy Use on Verbal Memory Performance in Adolescent and Emerging Adults: A Pilot StudyThe ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), methamphetamine and D-amphetamine.Pharmacokinetics and pharmacodynamics of 3,4-methylenedioxymethamphetamine (MDMA): interindividual differences due to polymorphisms and drug-drug interactions.Changes in serotonin transporter (5-HTT) gene expression in peripheral blood cells after MDMA intake.3,4-methylenedioxymethamphetamine induces gene expression changes in rats related to serotonergic and dopaminergic systems, but not to neurotoxicity.A genetic deletion of the serotonin transporter greatly enhances the reinforcing properties of MDMA in rats.Ecstasy use and depression: a 4-year longitudinal study among an Australian general community sample.Depressive mood ratings are reduced by MDMA in female polydrug ecstasy users homozygous for the l-allele of the serotonin transporter.Median and Dorsal Raphe Serotonergic Neurons Control Moderate Versus Compulsive Cocaine Intake.Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 2 h apart.Sex differences in 3,4-methylenedioxymethamphetamine (MDMA; ecstasy)-induced cytochrome P450 2D6 inhibition in humans.
P2860

5-HTTLPR polymorphism, mood disorders and MDMA use in a 3-year follow-up study.

Item
http://www.wikidata.org/entity/Q43251705
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
5-HTTLPR polymorphism, mood disorders and MDMA use in a 3-year follow-up study.
@en
5-HTTLPR polymorphism, mood disorders and MDMA use in a 3-year follow-up study.
@nl
type
label
5-HTTLPR polymorphism, mood disorders and MDMA use in a 3-year follow-up study.
@en
5-HTTLPR polymorphism, mood disorders and MDMA use in a 3-year follow-up study.
@nl
prefLabel
5-HTTLPR polymorphism, mood disorders and MDMA use in a 3-year follow-up study.
@en
5-HTTLPR polymorphism, mood disorders and MDMA use in a 3-year follow-up study.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
5-HTTLPR polymorphism, mood disorders and MDMA use in a 3-year follow-up study.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1369-1600.2009.00180.X
P433
P478
P50
P577
P5875
P698